Viatris Inc (VTRS)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$11.93

Buy

$12.15

arrow-down$-0.01 (-0.08%)

Prices updated at 20 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

Mylan NV is a generic pharmaceutical manufacturer which develops, licenses, manufactures, markets and distributes generic, over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories.

NASDAQ

1.31%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	15,427m	14,739m
	6,439m	5,624m
	983m	389m
	6.37	2.64
	55m	-634m
	3,517m	2,820m
Sales, General and administrative	4,650m	4,426m
Interest expenses	573m	550m
Provision for income taxes	148m	11m
Operating expenses	5,455m	5,234m
Income before taxes	203m	-623m
Net income available to common shareholders	55m	-634m
	0.05	-0.53
Net interest income	-573m	-550m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.05	-0.53
Free cash flow per share	1.6728	1.5806
Book value/share	17.3771	16.5814
Debt equity ratio	0.799002	0.762963

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	12,976m	9,521m
Current liabilities	7,777m	5,779m
Total capital	36,656m	32,674m
Total debt	18,371m	14,306m
Total equity	20,467m	18,636m
Total non current liabilities	-	-
Loans	16,188m	14,039m
Total assets	47,686m	41,501m
Total liabilities	-	-
Cash and cash equivalents	992m	735m
Common stock	1,201m	1,194m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	1,263m	994m
Cash dividends paid	-576m	-575m
	2,325m	1,944m
Investments (gains) losses	-764m	1,801m
	994m	736m
Net income	-	-
	2,800m	2,303m
	-474m	-359m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.